Fish oil may help curb seizure frequency in epilepsy

Low doses might be helpful in epilepsy that no longer responds to drug treatment

2014-09-09

(Press-News.org) But high doses were no better than dummy (placebo treatment), the findings indicated.

The omega-3 fatty acids found in fish oil are able to cross over from the bloodstream into heart cells where they work to stabilise heart rhythm and protect against heart attacks.

This is particularly important for people with epilepsy because they have a significantly higher risk of having a heart attack than those without the condition.

And experimental research indicates that omega 3 fatty acids can also cross over into the central nervous system, where they reduce the excitability of brain cells which trigger seizures.

But previous research looking at the impact of high dose fish oil on seizure frequency in people whose epilepsy no longer responded to treatment, found that it didn't affect seizure frequency.

The researchers in the current study wanted to know what difference, if any, low dose fish oil made to seizure frequency and/or cardiovascular health.

Twenty four people, whose epilepsy was no longer responsive to drugs were therefore given three separate treatments, each lasting 10 weeks, and separated by a period of 6 weeks.

These comprised: 3 capsules of fish oil daily (low dose) equivalent to 1080 mg omega-3 fatty acids every day, plus 3 capsules of corn oil (placebo); 6 capsules of fish oil daily, equivalent to 2160 mg every day; and 3 capsules of corn oil twice a day.

The average number of seizures among those taking low dose fish oil was around 12 a month. This compares with just over 17 for the high dose, and just over 18 for the placebo, equivalent to a fall of a third (33.6%) in the number of seizures while on the low dose.

Two people on the low dose were completely seizure free during the 10 week trial. No one taking the high dose fish oil or the placebo was seizure free.

Low dose fish oil was also associated with a modest fall in blood pressure of 1.95 mm Hg over the 10 week period, unlike high dose fish oil which was associated with an average increase of 1.84 mm Hg.

But fish oil was not associated with any changes in heart rate or blood fat levels, or severity of seizures.

The researchers caution that a much larger study is needed to confirm or refute these findings before any firm conclusions can be drawn, and recommendations made.

But they write: "Low dose fish oil is a safe and low cost intervention that may reduce seizures and improve cardiovascular health in people with epilepsy."

INFORMATION: END

ELSE PRESS RELEASES FROM THIS DATE:

Study of almost 900,000 people shows prediabetes increases the risk of cancer by 15 percent

2014-09-09

A meta-analysis comprising 16 studies and 891,426 participants from various regions of the world shows that prediabetes increases the risk of cancer by 15%, with differing risks depending on the type of cancer. The study, published in Diabetologia (the journal of the European Association for the Study of Diabetes) is by Professor Yuli Huang, The First People's Hospital of Shunde, Daliang Town, Shunde District, China, and colleagues. Prediabetes is a general term that refers to an intermediate stage between normoglycaemia and overt diabetes mellitus. It includes individuals ...

E-cigarette nicotine refill cartridges pose danger for toddlers

2014-09-09

The safety of nicotine refill cartridges used in electronic cigarettes needs to be improved to prevent toddlers accidentally swallowing the contents and potentially coming to serious harm, warn doctors in Archives of Disease in Childhood. The warning follows their treatment of a suspected case in the UK and emerging US data on the substantial rise of unintentional nicotine poisoning from e-cigarettes among the under 5s. The UK toddler was brought into the emergency care department of Good Hope Hospital in Birmingham after the child's mother had spotted her picking up ...

The Lancet Respiratory Medicine: Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial)

2014-09-09

This study of 1358 children investigated whether intermittent montelukast (a drug widely used to treat wheeze and other asthmatic symptoms) compared with placebo, reduced wheezing episodes in children aged 10 months to 5 years, and whether patient outcome differed according to genotype. Study authors found that intermittent montelukast only reduced wheezing episodes in children with arachidonate 5-lipoxygenase (ALOX5) gene promoter 5/5, a gene that has previously been associated with a better response to montelukast in adults. There was no correlation with reduced wheezing ...

Tip sheet from Annals of Internal Medicine, Sept. 9, 2014

2014-09-09

1. Health insurance not affordable for many under Affordable Care Act For many younger adults, the penalty for not buying health insurance may be less than the price of the least expensive plan available under the Patient Protection and Affordable Care Act (ACA), according to a study being published in Annals of Internal Medicine. The ACA aims to expand health care coverage in part by providing subsidies to individuals with low annual incomes. The law mandates that individuals purchase health insurance or pay a penalty. The penalty is waived if the cost of the least-expensive ...

Should lung cancer screening be covered for Medicare beneficiaries?

2014-09-09

1. Should lung cancer screening be covered for Medicare beneficiaries? Experts analyze evidence from the National Lung Screening Trial Researchers for the Centers for Medicare and Medicaid Services (CMS) analyze evidence on the benefits and harms of lung cancer screening by age in a study being published in Annals of Internal Medicine. Smoking is the most important risk factor for developing lung cancer. The National Lung Screening Trial (NLST) reported a reduction in lung cancer mortality in high-risk participants aged 55 to 74 who were randomly assigned to screening ...

September/October 2014 Annals of Family Medicine Tip Sheet

2014-09-09

Illinois' Medicaid Primary Care Case Management Program Associated With Substantial Savings, Reductions in Inpatient and Emergency Care and Improvements in Quality Measures Illinois was an early leader in comprehensive Medicaid reform, implementing a primary care case management program, Illinois Health Connect, and a complementary disease management program, Your Healthcare Plus, in 2006. The programs aimed to promote preventive care, reduce the redundancy of services through continuity of care with a primary care provider, and improve the management of chronic diseases. ...

Researchers improve severe asthma care through new, antibody-based treatment

2014-09-09

September 8, 2014 – Hamilton, ON – A team of researchers at McMaster University and St. Joseph's Healthcare Hamilton have successfully evaluated a new, antibody-based drug for certain patients with severe asthma. The drug – named mepolizumab – can replace traditional, steroid-based treatments for a specific subset of patients, resulting in improved outcomes and reduced side effects. The study and manuscript, published in the New England Journal of Medicine was led in Canada by Dr. Parameswaran Nair, staff respirologist, Firestone Institute for Respiratory Health at ...

Patients with advanced dementia continue receiving medications of questionable benefit

2014-09-08

Bottom Line: More than half of nursing home residents with advanced dementia (a terminal illness marked by severe cognitive impairment and functional dependence) continue to receive medications of questionable benefit (including medications to treat dementia and lower cholesterol) at substantial financial cost. Author: Jennifer Tjia, M.D., M.S.C.E., of the University of Massachusetts Medical School, Worcester, and colleagues. Background: The Institute of Medicine recommends clinicians minimize interventions in patients with life-limiting disease and instead focus ...

Access to care among young adults increases after health insurance expansion

2014-09-08

Bottom Line: Health insurance coverage increased, as expected, among 19- to 25-year-olds after the Patient Protection and Affordable Care Act (PPACA) allowed them to remain on their parents' insurance longer but there were no significant changes in perceived health status or the affordability of health care. Author: Meera Kotagal, M.D., M.P.H., of the University of Washington, Seattle, and colleagues. Background: Nearly 1 in 3 young adults ages 19 to 25 years lacked health insurance in 2009. An early provision of the PPACA implemented in 2010 mandated that insurance ...

Study examines immunosuppressant effect on central nervous system disorder

2014-09-08

Bottom Line: In patients with neuromyelitis optica spectrum disorder (NMOSD, an autoimmune inflammatory disease of the central nervous system similar to multiple sclerosis but even more debilitating), the immunosuppressant medication mycophenolate mofetil (MMF) appears to reduce the frequency of relapse, stabilize or improve disabilities and be well tolerated by patients. Author: So-Young Huh, M.D., of the University College of Medicine, Busan, Korea, and colleagues. Background: Disabilities from NMOSD arise due to acute attacks and just one or two attacks can lead ...

Wiley advances Knowitall Solutions with new trendfinder application for user-friendly chemometric analysis and additional enhancements to analytical workflows

Fish oil may help curb seizure frequency in epilepsy

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: